results of clinical trials of acyclovir for prevention and treatment of herpes simplex , varicella-zoster virus , cytomegalovirus , and epstein-barr virus infections are discussed , and the potential problem of antiviral resistance considered .
C0001367
acyclovir
C0149678
epstein-barr virus infections